UNSPSC 51124401: Acetyldigoxin

This classification denotes a digoxin, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P7K44M64CW. European Medicines Agency schedules Acetyldigoxin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12718MIG. Acetyldigoxin generally arises in the molecular formula C43H66O15. The term 'acetyldigoxin' is a European Pharmacopoeia designation. SMILES: OC12C3C(C4(C(CC3)CC(OC3OC(C(OC5OC(C(OC6OC(C(OC(=O)C)C(O)C6)C)C(O)C5)C)C(O)C3)C)CC4)C)CC(O)C1(C(CC2)C1=CC(=O)OC1)C.

UNSPSC 51124401 Acetyldigoxin is a Commodity code covering pharmaceutical active ingredients and finished medications supplied to state and local health systems, emergency services, and medicaid programs. State and local governments procure under this code to stock emergency medications, institutional pharmacy inventories, and medicaid-covered prescriptions. Recent solicitations show demand for specific advanced life support injectables (epinephrine, adenosine, diltiazem, labetalol) supplied to fire rescue and emergency medical services, as well as broader generic pharmaceutical and over-the-counter product lines distributed through state and local healthcare networks. Issuing bodies include city purchasing departments managing fire rescue procurement (City of Tampa), state health agencies overseeing medicaid and employee health benefits (Texas Health and Human Services Commission), and cooperative purchasing alliances aggregating demand across multiple state and local jurisdictions (Minnesota Multistate Cooperative Purchasing Alliance administering purchases on behalf of Minnesota, Oregon, and other participating states and localities).

Activity is concentrated in Texas and Minnesota, with the City of Tampa representing municipal fire rescue demand in Florida. The City of Tampa issued IFB 26P00188 on April 24, 2026, with a due date of April 8, 2026 (note: posted date is after due date, indicating this opportunity has closed), soliciting sealed bids for Advanced Life Support Medications for Tampa Fire Rescue with an estimated value of $40,000 and a one-year contract term plus renewal options; the solicitation included a 5 percent bid discount for Small Local Business Enterprise participation, capped at $10,000. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 due March 26, 2026, establishing multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities including Oregon; vendors must supply through three authorized wholesalers and meet cGMP and Drug Supply Chain Security Act compliance with a two-year contract term. The Texas Health and Human Services Commission issued RFI HHS0017013 in March 2026 to gather vendor capabilities regarding direct-to-manufacturer pharmaceutical prescription programs, signaling early-stage procurement development in that state.